MA Startup Hits Back at Damning Report as SEC Investigates
February
12
The tech-focused Medicare Advantage startup Clover Health — which should be riding high after its recent stock market debut — is instead being probed by the Securities and Exchange Commission and is facing a shareholder lawsuit amid allegations it misled investors by failing to publicly disclose that it was being investigated by the Dept. of Justice.
While the company has denied the allegations via a lengthy, public rebuttal, securities law experts tell AIS Health that Clover could face liability if it did actually conceal material information from investors — a fact that hasn’t yet been determined.
© 2024 MMIT
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Senior Editor, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile